Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

EBV and systemic lupus erythematosus: a new perspective.

Gross AJ, Hochberg D, Rand WM, Thorley-Lawson DA.

J Immunol. 2005 Jun 1;174(11):6599-607.

2.

Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus.

Kang I, Quan T, Nolasco H, Park SH, Hong MS, Crouch J, Pamer EG, Howe JG, Craft J.

J Immunol. 2004 Jan 15;172(2):1287-94.

3.

Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.

Niller HH, Wolf H, Minarovits J.

Autoimmunity. 2008 May;41(4):298-328. doi: 10.1080/08916930802024772. Review.

PMID:
18432410
4.

Acute viral infections in patients with systemic lupus erythematosus: description of 23 cases and review of the literature.

Ramos-Casals M, Cuadrado MJ, Alba P, Sanna G, Brito-Zerón P, Bertolaccini L, Babini A, Moreno A, D'Cruz D, Khamashta MA.

Medicine (Baltimore). 2008 Nov;87(6):311-8. doi: 10.1097/MD.0b013e31818ec711. Review.

5.
6.
7.

Association of Epstein-Barr virus with systemic lupus erythematosus: effect modification by race, age, and cytotoxic T lymphocyte-associated antigen 4 genotype.

Parks CG, Cooper GS, Hudson LL, Dooley MA, Treadwell EL, St Clair EW, Gilkeson GS, Pandey JP.

Arthritis Rheum. 2005 Apr;52(4):1148-59.

8.

Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure.

James JA, Neas BR, Moser KL, Hall T, Bruner GR, Sestak AL, Harley JB.

Arthritis Rheum. 2001 May;44(5):1122-6.

9.

Exhausted cytotoxic control of Epstein-Barr virus in human lupus.

Larsen M, Sauce D, Deback C, Arnaud L, Mathian A, Miyara M, Boutolleau D, Parizot C, Dorgham K, Papagno L, Appay V, Amoura Z, Gorochov G.

PLoS Pathog. 2011 Oct;7(10):e1002328. doi: 10.1371/journal.ppat.1002328. Epub 2011 Oct 20.

10.

Phenotypic and functional analysis of EBV-specific memory CD8 cells in SLE.

Berner BR, Tary-Lehmann M, Yonkers NL, Askari AD, Lehmann PV, Anthony DD.

Cell Immunol. 2005 May;235(1):29-38. Epub 2005 Sep 19.

PMID:
16181618
11.
12.

Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo.

Hochberg D, Middeldorp JM, Catalina M, Sullivan JL, Luzuriaga K, Thorley-Lawson DA.

Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):239-44. Epub 2003 Dec 19.

13.

EBV lytic-phase protein BGLF5 contributes to TLR9 downregulation during productive infection.

van Gent M, Griffin BD, Berkhoff EG, van Leeuwen D, Boer IG, Buisson M, Hartgers FC, Burmeister WP, Wiertz EJ, Ressing ME.

J Immunol. 2011 Feb 1;186(3):1694-702. doi: 10.4049/jimmunol.0903120. Epub 2010 Dec 29.

14.

EBV-infected B cells in infectious mononucleosis: viral strategies for spreading in the B cell compartment and establishing latency.

Kurth J, Spieker T, Wustrow J, Strickler GJ, Hansmann LM, Rajewsky K, Küppers R.

Immunity. 2000 Oct;13(4):485-95.

15.

Epstein-Barr virus and systemic lupus erythematosus.

James JA, Harley JB, Scofield RH.

Curr Opin Rheumatol. 2006 Sep;18(5):462-7. Review.

PMID:
16896283
16.

Functional Epstein-Barr virus reservoir in plasma cells derived from infected peripheral blood memory B cells.

Al Tabaa Y, Tuaillon E, Bollore K, Foulongne V, Petitjean G, Seigneurin JM, Duperray C, Desgranges C, Vendrell JP.

Blood. 2009 Jan 15;113(3):604-11. doi: 10.1182/blood-2008-02-136903. Epub 2008 Oct 9.

17.

Epstein-Barr virus in autoimmune diseases.

Toussirot E, Roudier J.

Best Pract Res Clin Rheumatol. 2008 Oct;22(5):883-96. doi: 10.1016/j.berh.2008.09.007. Review.

PMID:
19028369
18.
19.

Systemic lupus erythematosus associated with acute Epstein-Barr virus infection.

Dror Y, Blachar Y, Cohen P, Livni N, Rosenmann E, Ashkenazi A.

Am J Kidney Dis. 1998 Nov;32(5):825-8.

PMID:
9820454
20.

Supplemental Content

Support Center